3BARBURT F,CORTHIER G,CHARPAK Y,el al. Prevalence and pathogenicity of Clostridium difficile in hospilalized patients [ J ]. Arcb Inter Med, t 996,156 ( 13 ) : 1449 - 1454.
4GERDING DN, JOHNSON S, PETERSON LR,et al. Society for heahhcare epidemiology of America position paper on Clostridium difficile-associated diarrhea and colitis [ J ]. Infect Control Hosp Epidemol,1995,16(8) :459 - 477.
6JOHNSON S,HONMAN SR,BETTIN KM,et al. Treatment of asymptomatic Clostridium difficile carriers (fecal errors) with vancomyein or metronidazole[ J ].Ann Inter Med,1992,117(4) :297 -302.
7OLSON MM,SHANHOLTZR CJ,I,EE JT JR,et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982 - 1991 [ J ]. Infrect Control Hosp Epidemiol, 1994,15 ( 6 ) : 371 - 381.
8TEASLEY DG,GERDING DN,OLSON MM,et al. Randomized controlled trial of vancomycin for Clostridium difficile-associated diarrhea and colitis[J]. Lancet,1983,322(8358) :1043 - 1046.
9FEKERTY R. Guidelines for diagnosis and management of Clostridium difficile-associated diarrhea and colitis [ J ]. Am J Gastroenterol, 1997,92(5) :739 - 750.
10FEKETY R,KIRKPATRICK J,FORWORD K,et al. Treatment ot antiMotic associated Clostridium difficile colitis with oral vaneomycin:comparison of two dosage regimen t [J]. Am J Med, 1989,86 (1):15-19.
